TSANZ home

Results for "nursing"

Home 5 Search query for: nursing
Results for "nursing"
VOLUME 6.03 – MARCH 2021

VOLUME 6.03 – MARCH 2021

Research Roundup:

March 2021

Welcome Message

We hope you’ve been keeping safe and well.

The TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship is now open. This award aims to facilitate the establishment of mid-career invenstigators as independent, self-directed researchers and to foster the development of high-quality respiratory research in Australia and New Zealand.

Please note that the TSANZ Indigenous Respiratory Nursing Award will be closing 12 April 2021 and the Boehringer Ingelheim New Zealand Primary Care Award will be closing 05 April 2021.

 

Don’t forget to register for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Indigenous Respiratory Nursing Award – extended – closing 12 April 2021

Boehringer Ingelheim New Zealand Primary Care Award – closing 05 April 2021

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

  

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

2021 Australian Museum Eureka Prizes

Do you know someone making a difference in their field?

Entries to the 2021 Australian Museum Eureka Prizes are now open!

This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

If you know an individual or team doing outstanding work, why not encourage them to enter?

Entries close 7pm AEST Friday 28 May

VIEW THE FULL PRIZE PROGRAM

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Respirology – Editor’s Choice

Respirology Issue 26.3 March 2021

The impact of regular bisoprolol on the response to salbutamol in asthma: A double-blind randomized placebo-controlled crossover trial

Miriam R. Bennett, Catherina L. Chang, Chris Tuffery, Sandra Hopping and Robert J. Hancox

DOI: 10.1111/resp.13955

Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study

Tom J.C. Ruffles, Julie M. Marchant, Ian B. Masters, Stephanie T. Yerkovich, Danielle F. Wurzel, Peter G. Gibson, Greta Busch, Katherine J. Baines, Jodie L. Simpson, Heidi C. Smith-Vaughan, Susan J. Pizzutto, Helen M. Buntain, Gregory Hodge, Sandra Hodge, John W. Upham and Anne B. Chang

DOI: 10.1111/resp.13950

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

ASCOT ADAPT includes 3 treatment domains:

Domain A (Antiviral)

  1. Standard of care
  2. Standard of care + nafamostat

Domain B (Antibody)

  1. Standard of care
  2. Standard of care + convalescent plasma

Domain C (Anticoagulation)

  1. Standard dose thromboprophylaxis
  2. Intermediate dose thromboprophylaxis
  3. Standard dose thromboprophylaxis plus aspirin

Eligible patients can be randomised to one or more domains concurrently.

Protocol documents and further details are available at www.ascot-trial.edu.au

 Australasian Society for Medical Research message

The Thoracic Society is an affiliate member of the ASMR. Please see below for their latest communications.

Dear ASMR member

The Australian National Audit Office has informed us that an audit of ‘Health’s Management of the Medical Research Future Fund’ is currently open for contribution. The period for submissions is expected to close on 30 May 2021 and the audit report will be tabled in September 2021.

“The objective of this audit is to assess whether the Department of Health is effectively managing the Medical Research Future Fund (MRFF)” with respect to the following criteria:

  • “Are the MRFF governance arrangements effective?”
  • “Has MRFF legislation, governance, strategies and priorities guided selection of medical research initiatives?”
  • “Does Health effectively monitor, measure and evaluate MRFF’s performance?”

Submissions are confidential and can be anonymous (name, address and contact number fields provided are not required for a submission) so I encourage you and your extended networks to contribute instances or evidence around issues relating to the audit criteria for an ASMR submission (please send to president@asmr.org.au), or if you prefer, make a submission directly to the audit webpage.

While the addition of the MRFF to the health and medical research funding landscape is greatly welcomed, since its inception in 2014, Australian clinicians and researchers have expressed concerns about the MRFF processes and governance. I therefore cannot stress the importance of providing accurate, appropriate and verifiable submissions to the auditors with regard to the audit objective and criteria.

 

Yours sincerely,
Dr Ryan Davis
ASMR President 2021

Surveys and Research

SURVEY OF LUNG CANCER CARE IN AUSTRALIA

We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

  • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
  • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
  • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

Thank you for your time.

Prof Fraser Brims
Curtin Medical School
fraser.brims@curtin.edu.au 

TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

This study has now been completed and below is a summary of the findings from this work.

The top 3 priorities rank by people with PF and caregivers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. What medications can improve lung function in people with PF?
  3. What are the causes of PF?

The top 3 priorities rank by people with healthcare professionals/researchers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. How can we prevent PF?
  3. What are the causes of PF?

The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

(click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

Yours sincerely,

Anne Holland
Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

VOLUME 6.03 – MARCH 2021

VOLUME 6.02 – FEBRUARY 2021

Research Roundup:

February 2021

Welcome Message

We hope you’ve been keeping safe and well.

We are pleased to announce that the Boehringer Ingelheim New Zealand Primary Care Grant is now open. This grant aims to support research in respiratory health within the primary care sphere in New Zealand. Primary care can include general practice, allied health services, nursing in community health and community pharmacy.

Please note that a number of awards are closing this Wednesday 24 February. These include our modified travel awards that take into account travel bans and restrictions.

Don’t forget to register for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the February edition of your Research Roundup.

Prof Sandra Hodge
Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Indigenous Respiratory Nursing Award – closing 01 April 2021

Boehringer Ingelheim New Zealand Primary Care Award – closing 05 April 2021

TSANZ National Asthma Council Australia – Asthma & Airways Fellowship – closing 31 May 2021

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Grifols Scientific Awards

The 18th Annual ALTA Alpha-1-Antitrypsin Laurell’s Training Award is now open.

Deadline for submission of letter of intent – 1 March 2021

Deadline for submission of full proposal – 31 May 2021

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Respirology – Editor’s Choice

Respirology Issue 26.2 February 2021

Effects of roflumilast on arterial stiffness in COPD (ELASTIC): A randomized trial

Matthias H. Urban, Nicole Kreibich, Andreas Gleiss, Georg-Christian Funk, Sylvia Hartl and Otto C. Burghuber

DOI: 10.1111/resp.13914

 ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

ASCOT ADAPT includes 3 treatment domains:

Domain A (Antiviral)

  1. Standard of care
  2. Standard of care + nafamostat

Domain B (Antibody)

  1. Standard of care
  2. Standard of care + convalescent plasma

Domain C (Anticoagulation)

  1. Standard dose thromboprophylaxis
  2. Intermediate dose thromboprophylaxis
  3. Standard dose thromboprophylaxis plus aspirin

Eligible patients can be randomised to one or more domains concurrently.

Protocol documents and further details are available at www.ascot-trial.edu.au

Surveys and Research

SURVEY OF LUNG CANCER CARE IN AUSTRALIA

We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

  • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
  • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
  • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

Thank you for your time.

Prof Fraser Brims
Curtin Medical School
fraser.brims@curtin.edu.au 

TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

This study has now been completed and below is a summary of the findings from this work.

The top 3 priorities rank by people with PF and caregivers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. What medications can improve lung function in people with PF?
  3. What are the causes of PF?

The top 3 priorities rank by people with healthcare professionals/researchers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. How can we prevent PF?
  3. What are the causes of PF?

The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

(click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

Yours sincerely,

Anne Holland
Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 6.03 – MARCH 2021

VOLUME 6.01 – JANUARY 2021

Research Roundup:

January 2021

Welcome Message

Welcome to the first edition of our TSANZ Research Roundup for 2021. We hope you’ve kept safe and well over the festive season.

The TSANZ Indigenous Respiratory Nursing Award is now open. This award aims to raise the profile of indigenous health within respiratory nursing and the work of respiratory nurses of an indigenous background.

The TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health has been extended to 24 February 2021. This award, to honour the memory of the late Prof. Rob Pierce, will be awarded to a member of the TSANZ for a project focused on understanding and improving the lung health of Indigenous people in Australia and/or New Zealand.

Our two travel awards, TSANZ Janet Elder International Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been extended to 24 February 2021. These awards have been modified to allow for professional development or research support instead of travel should the international scientific meetings not proceed or travel restrictions prevent you from attending.

Don’t forget to take advantage of the earlybird prices for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the January edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

Open Awards

Thoracic Society Awards

TSANZ Janet Elder International Travel Award – extended – closing 24 February 2021

Boehringer Ingelheim New Zealand COPD Travel Award – extended – closing 24 February 2021

TSANZ Peter Phelan Research Grant – closing 27 January 2021

Maurice Blackburn Occupational Lung Disease Grant-in-Aid – closing 27 January 2021

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – extended – closing 24 February 2021

TSANZ Indigenous Respiratory Nursing Award – closing 24 February 2021

Cystic Fibrosis Australia Awards

Australian Cystic Fibrosis Research Trust 2021 Innovation Grant – closing 29 January 2021

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

PACT Grant-in-Aid – closing 14 February 2021

CREATE Grant-in-Aid – closing 14 February 2021

     

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

 

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Register now to take advantage of the earlybird prices. Earlybird registrations will be available until 12 February 2021.

 

Respirology – Editor’s Choice

Respirology Issue 26.1 January 2021

 

Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap

Sarah A. Hiles, Peter G. Gibson and Vanessa M. McDonald

DOI: 10.1111/resp.13841

 

Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial

Fanny Wai-San Ko, Wilson Tam, Eddy H.S. Siu, Ka-Pang Chan, Jenny Chun-Li Ngai, So-Shan Ng, Tat On Chan1 and David Shu-Cheong Hui

DOI: 10.1111/resp.13872

 

 ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

ASCOT ADAPT includes 3 treatment domains:

Domain A (Antiviral)

  1. Standard of care
  2. Standard of care + nafamostat

Domain B (Antibody)

  1. Standard of care
  2. Standard of care + convalescent plasma

Domain C (Anticoagulation)

  1. Standard dose thromboprophylaxis
  2. Intermediate dose thromboprophylaxis
  3. Standard dose thromboprophylaxis plus aspirin

Eligible patients can be randomised to one or more domains concurrently.

Protocol documents and further details are available at www.ascot-trial.edu.au

VOLUME 6.03 – MARCH 2021

VOLUME 4.09 NOVEMBER 2019

Research Roundup:

November 2019

.
 

Welcome Message

We are now in the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Sub-committee is in full swing reviewing award applications, the SIG convenors are reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2020, we are expecting another large conference, having received approximately 440 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2020.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

Lund Foundation Australia Research Awards 

  • Cochrane Airways Australia Scholarship – extended to 15 November 2019

To download application documents, click here.

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

TSANZ Webinar Series

 

“Tracheostomy tubes and principles of management” with Gavin Fahey

Event Date: Thursday, 14th of November 2019

Time: 2:30pm AEDT

Duration: 45 minutes

A presentation covering anatomy and physiology, tube selection, principles of nursing and emergency management.

Only limited places available! Don’t miss out!

The presenter: Gavin Fahey

Gavin Fahey currently works as Senior Respiratory Clinical Nurse Consultant (CNC) at Northern Health (NH) leading a team of Respiratory CNCs who since 2018 have collectively contributed to acquisition and management of oxygen services across NH, development of a 4-bed Respiratory Care Unit caring for patients with severe respiratory failure, and improving lung mass services incorporating development of Victoria’s first Specialist Ambulatory Pleural Service. Gavin’s experience includes working within both the Victorian Respiratory Support Service and Tracheostomy and Management Service (Austin Health) utilising his experience and advanced understanding of tracheostomy and ventilation management within the acute and outpatients setting.

CLICK HERE to register! 

_______________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 24.11 November 2019

Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial

Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton

DOI: 10.1111/resp.13575

Nasal High Flow therapy in use

BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo

Rebecca L. Harper, Suzanne Maiolo, Rebekah J. Ward, Jemma Seyfang, Michaelia P. Cockshell, Claudine S. Bonder, Paul N. Reynolds

Putative mechanism of cell therapy upregulating BMPR2 in pulmonary vessels via release of exosomes

DOI: 10.1111/resp.13552

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

Dear TSANZ Members,

Lung Foundation Australia, with the support of nursing members of the Australia and New Zealand – Lung Cancer Nurse Forum, invite you to the next workshop in the series: Treatment Modalities and Management of a Stage 3 NSCLC Patient workshop, in Hobart on Friday 29 November 2019.

These workshops are open to nurses and allied health with an interest in working with and caring for people with lung cancer.

Date: Friday 29 November 2019

Time: 9:30am – 12:30pm

Location: Cancer Support Centre, Royal Hobart Hospital, 48 Liverpool St, Hobart TAS 7000

Program: Medical experts including nurses, medical oncology and radiation oncology specialists, and allied health professionals will discuss the management of a Stage III unresectable lung cancer patient.

More information about the agenda and speakers are coming soon. Please see our website for up to date information on this workshop.

Workshops are free to attend and you will be provided with a certificate for your hours of learning.

Register here

Please RSVP by Friday 22 November 2019. Registrations are essential for seating and catering purposes. For more information on the event, please visit our website here.

For further queries, please contact our information and support centre freecall on 1800 654 301 or email enquiries@lungfoundation.com.au.

We hope to see you on the day!

Kind Regards,

Lung Foundation Australia

 

                                                                                                                                                              

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 6.03 – MARCH 2021

VOLUME 4.07 SEPEMBER 2019

Research Roundup:

September 2019

.
 

Welcome Message

Welcome to the September Issue. Many of our current TSANZ Awards will be closing next month, following the Abstract Submission deadline for our TSANZSRS2020 ASM. Preparations are well and truly underway for the ASM so we hope to see you there and presenting your work!

If you are interested in attending the APSR Congress in November, we have one LFA A/Menarini Travel Award closing on 13 September to sponsor those researching or involved in COPD.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. If you have been trying to uncover some hidden academic riches locked away in the recesses of respiratory research, we want to hear about it! You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

TSANZ Peter Phelan Research Award – closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards APSR closing 13th September 2019 (5pm AEST)

Lung Foundation Australia / Brian Eaton PhD IPF Scholarship 2019EXTENDED closing date 30 October 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.9 September 2019

Special Issue on Pulmonary Fibrosis Awareness Month

 

In support of Pulmonary Fibrosis Awareness month September, Respirology offers free access to selected articles during the month of September 2019.
The articles will be available at
https://onlinelibrary.wiley.com/page/journal/14401843/pf-awareness-month-2019

Research Project and Survey Requests

Dear TSANZ Members,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice in regards to Advance Care Planning in patients with chronic obstructive pulmonary disease (COPD). 

This study is being conducted by:
Ms Mary Roberts, Dr Tracy Smith, Professor Wheatley and Dr Jin-Gun Cho. Details and affiliations of the research team can be obtained by contacting Ms Mary Roberts by phone 0408 490 371 or email mary.roberts@health.nsw.gov.au

The results of the survey will form part of a research project with the aim to develop resources to improve the quality and uptake of advanced care planning in patients with COPD. This survey has been approved by the WSLHD HREC under authorisation number 5990 2019/ETH00197.

The estimated time to complete the survey is 10-15 minutes. If you exit out the survey early or don’t click DONE on the final page, your responses will not be saved. You may skip questions if you wish, though we would prefer you didn’t.  

Your participation is voluntary and anonymous. Your contribution is greatly appreciated.
We thank you in advance for your participation.
Here is the link: https://www.surveymonkey.com/r/8S6TLF6

Sincerely,

Ms MM Roberts

Mary Roberts

Clinical Nurse Consultant | Respiratory Ambulatory Care

Clinical Lecturer, Sydney Medical School, University of Sydney

 

Determining a Patient-Centred Model of Care in Severe Asthma: What can we learn from the views, needs, and challenges of Clinicians’ and Carers of people with Severe Asthma and COPD?

Phase 1- Clinicians’ group

Investigators: Dr Vanessa Clark, Professor Vanessa McDonald, Professor Peter Gibson, and Eleanor Majellano

Invitation

You are invited to participate in a research study that explores the barriers and facilitators to the optimal management of severe asthma. This research is being conducted as part of the requirements for a PhD at the University of Newcastle by Eleanor Majellano, under the supervision of Professor Vanessa McDonald and Dr Vanessa Clark. We are investigating the barriers, facilitators and attitudes of clinicians and allied healthcare professionals towards the optimal management of severe asthma in various healthcare settings.

Before you decide whether or not you wish to participate in this study, it is important for you to understand why the research is being conducted and what it will involve.

Please download the information and participation forms here if you are interested or would like to contact the investigators:

Participation Information Sheet.

This study has been approved by the Hunter New England Human Research Ethics Committee Reference. If you have concerns or complaints about the conduct of this study you should contact:

Dr. Nicole Gerrand

Manager

Research Ethics & Governance Office

Hunter New England Local Health District

   Email: HNELHD-HREC@health.nsw.gov.au

The manager is the person nominated to receive complaints from research participants.

You will need to quote reference number 2019/ETH00143.

 

Thank you for taking the time to consider this study.

If you wish to take part in it, please sign the attached consent form.

This information sheet is for you to keep.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 6.03 – MARCH 2021

VOLUME 4.06 AUGUST 2019

Research Roundup:

August 2019

.
 

Welcome Message

We received some exciting news with the announcement that the National Dust Disease Taskforce has been established by the Australian Government Department of Health. TSANZ and its members will play a key role in the Taskforce, enabling us to further contribute to the work we have been doing around preventable occupational lung disease.

Don’t forget to visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards, and keep in mind the closing date of October 11th. Our Open Awards section below highlights our ongoing awards, grants and scholarships from the Lung Foundation Australia.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. Details can be found here. Our most recent submission by Dr Jane Bourke is featured in this month’s the limbic section below.

We hope you enjoy the August edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

TSANZ Peter Phelan Research Award – closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards APSR closing 13th September 2019 (5pm AEST)

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 24.8 August 2019

Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score‐matched analysis

Hironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhasi, Dai Hashimoto, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Koshi Yokomura, Hidenori Nakamura, Takafumi Suda

Researchers from Hamamatsu University School of Medicine, Hamamatsu, Japan. From left to right: Prof. Takafumi Suda and Dr. Hironao Hozumi

DOI: 10.1111/resp.13506

 

Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions

Jose M. Porcel, Aureli Esquerda, Silvia Biesla, Anna Novell, Maria Alba Sorolla, Sonia Gatius, Carlos Zamora, Silvia Vidal, Antonieta Salud

 

The pleural research team at IRBLleida in Spain. From left to right: Drs Sorolla, Salud, Bielsa, Novell, Esquerda (behind) and Porcel.

DOI: 10.1111/resp.13539

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 6.03 – MARCH 2021

VOLUME 4.05 JULY 2019

Research Roundup:

July 2019

.
 

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. The wheels have officially begun turning for our 2020 TSANZ ASM, which means a wide range of opportunities to submit abstracts and will be opening on 12 July! Please visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards once the submission portal is live, and pay close attention to the closing dates.
For our registered nurses, don’t forget about the TSANZ Indigenous Respiratory Nursing Awards, which will help support the cost of attendance to the TSANZ ASM for those with indigenous heritage, or working with indigenous communities in respiratory health.

We have a few new Lung Foundation Australia awards opening this month, so see below for details. Applications are still open for LFA/A Menarini travel grants for ERS and APSR – if you are interested in attending be sure to send in your submissions before the deadline. We have also extended the date for the Brian Eaton IPF award.
If you are planning on attending the TSANZ New Zealand Annual Scientific Meeting, we still have travel grant applications open until 15 July so click here to apply now.

We would also like to bring to your attention the Bupa 2019 Emerging Health Researcher Awardnominations are open on their website. This award is designed for Early Career Researchers and the recipient will receive a prize of $25,000 to put towards further research. Selected Finalists and Highly Commended nominations will also be recognised.
icare also have opened their Dust Diseases Grant program to applicants, which closes 2 August. Please scroll down for more information on both.

We hope you enjoy the July edition of your Research Roundup!

 

Tanya Buchanan
(standing in for Sandra Hodge earning a well-earned break!)
CEO, The Thoracic Society of Australia and New Zealand

Open Awards

Thoracic Society Awards

TSANZ NZ ASM Travel Grants 2019 – closes 15th July 2019

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

Lung Foundation Awards

LFA / Brian Eaton IPF PhD Scholarship – EXTENDED until 14 July 2019 

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

N.B. The following awards will open 14 July

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

iCare Dust Diseases Grant Program

For all the application details, please visit https://www.icare.nsw.gov.au/injured-or-ill-people/work-related-dust-disease/research-and-funding/#gref.
If you have any questions or would like to know more about the program please contact: ddcgrants@icare.nsw.gov.au 

Bupa Health Foundation Emerging Health Researcher Award

The Bupa Health Foundation is seeking nominations for its 2019 Emerging Health Researcher Award.  

Nominations close on Monday 15th July 2019 (9AM AEST).

Award criteria and the nomination form can be found at https://www.bupa.com.au/about-us/bupa-health-foundation.

Should you have any queries, please contact Alana Fisher, Operations Manager, Bupa Health Foundation at foundation@bupa.com.au

_______________________________________________________________________________

Respirology – Editor’s Choice 

Respirology Issue 24.7 July 2019

Clinical usefulness of routine AFB culture and MTB PCR of EBUS‐TBNA needle rinse fluid

Ryoung-Eun Ko, Byeong-Ho Jeong, Hae Ri Chon, Hee Jae Huh, Joungho Han, Hyun Lee, Kyungjong Lee, Hojoong Kim, O. Jung Kwon, Sang-Won Um

 

Researchers from the Division of Pulmonary and Critical Care Medicine at the Samsung Medical Center in Seoul, South Korea. From left to right: Byoung-Ho Jeong, Sang-Won Um, and Ryoung-Eun Ko

DOI: 10.1111/resp.13488

 

Changes in physical activity during hospital admission for chronic respiratory disease

Mark W. Orme, Theresa C. Harvey-Dunstan, Ismet Boral, Emma J.L. Chaplin, S. Fayyaz Hussain, Mike D.L. Morgan, Michael C. Steiner, Sally J. Singh, Neil J. Greening

 

A single day of physical activity monitoring

DOI: 10.1111/resp.13513

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

 

Genomic medicine here to stay? Have your say.

Are you a medical specialist in Australia?

If so, tell us your thoughts about genomic medicine
practice and continuing medical education!

We need to hear from non-genetic medical specialists
who work clinically in Australia.

We want to know about past, present and future aspects
of genetics and health, including genomics in healthcare.

It doesn’t matter how much you know about this,
or whether you incorporate genomics into your practice or not;
your opinions, views and experiences are valuable to us.

You will help shape future workforce practices and
continuing education and training programs

Click here to complete the anonymous 15-minute survey.
Please distribute this link to your networks

Please note there are separate studies for clinical geneticists, oncologists, pathologists, radiologists and general practitioners, who will be contacted directly.

This survey is an activity of the Workforce Development Program of the NH&MRC-funded
Australian Genomics Health Alliance. If you have any queries, please contact Dr Amy Nisselle, Specialist Project Officer, Australian Genomics Health Alliance (amy.nisselle@mcri.edu.au or 03 9936 6340).

This survey has HREC approval, The University of Melbourne (1646785.8).

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 6.03 – MARCH 2021

VOLUME 4.02 APRIL 2019

Research Roundup:

April 2019

.
 

Welcome Message

The TSANZSRS19 was a great success and we thank all delegates and exhibitors for supporting respiratory research and professional development once again.

At TSANZSRS19 respiratory research received a much needed boost of funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and the Gala Dinner. Please find a re-cap of all the Thoracic Society Board Awards and Research Awards below, including the winners of the Special Interest Group Awards.

During the conference we opened a number of larger TSANZ awards, namely the AstraZeneca Respiratory Research Fellowships, which will support one early-career researcher and one mid-career researcher and the Vertex Cystic Fibrosis Research Awards, which will support one adult CF research project and one paediatric CF research project. There are also opportunities for IPF PhD scholarships and Menarini travel awards from the Lung Foundation. Links to these awards can be found in the Open Awards section below.

Enjoy the April edition of your research roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

$1 MILLION FOR LUNG DISEASE RESEARCH ANNOUNCED

Top lung health bodies raise much needed funds but more investment needed

(Thursday, 8th April 2019): Over a million dollars in lung research investment was announced over the weekend at the Respiratory Research Excellence Awards at the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science(TSANZSRS19) on the Gold Coast. The conference brings together Australia and New Zealand’s leading lung health experts to present latest research and improve knowledge and understanding of lung disease.

The Research Excellence Awards, run for the second year by Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of the conference – alongside the Lung Foundation, Cystic Fibrosis Australia and the National Asthma Council of Australia, provides over 40 researchers with support in the form of project funding, fellowships and travel grants raised through private donations, sponsorship and leveraged financing from recipients’ institutions.

“We’re honoured to be able to support some of Australia’s greatest minds in lung disease research; research that’s making a difference to the lives of the 1 in 4 Australians with lung disease,” said TSANZ President Elect Professor Bruce Thompson.

“This funding enables our researchers to build respiratory knowledge and capacity in the respiratory workforce, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” he said.

Despite the success of the Awards, the organisers warn that lung disease research is still grossly underfunded when compared to other diseases. Far more investment is required, they say.

“It’s important to recognise the exceedingly hard work that our organisations are putting in to raising the profile of respiratory research, and to express our thanks for the contribution of donors, sponsors and institutions This is only our second year and look at what we’ve achieved,” said TSANZ CEO Tanya Buchanan.

“However, fundraising alone is not the way to manage diseases affecting a quarter of Australians. Lung disease has to attract the same level of research funding enjoyed by other disease areas such as breast, prostate, and heart disease. We look forward to seeing if the implementation of the National Strategic Action Plan for Lung Conditions delivers this,” she said.

2019 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners. For information on how to apply for next year’s Awards visit the TSANZ website Research and Awards page.

Society Medal

Professor Helen Reddel

Research Medal

Professor Philip Hansbro

Laennec Medal

Professor Allan R Glanville

Ann Woolcock New Investigator Award

Jesse Armitage

Best training Video

Elizabeth Salamon, Selena West, Ursula Swan, Sandra Daly

CSL Behring TSANZ / LFA Alpha-1 Anti-trypsin Deficiency Research Award

Gang Liu

Australian Cystic Fibrosis Research Trust Innovation Grant

Gerard Kaiko, Peter Wark, Shafagh Water, and Adam Jaffe

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship

Kimberly Wang

Boehringer Ingelheim COPD Research Award 2019

Tatt Jhong Haw

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

Jane Bourke and Ryan Hoy

Boston Scientific Research Award for Interventional Pulmonology

Sanjeevan Muruganandan

Vertex Cystic Fibrosis Research Awards

ECFS: Elena Schneider-Futschik

NACFC: Rebecca Stockwell

TSANZ Peter Phelan Research Award

Elena Schneider-Futschik

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health

Gabrielle McCallum

TSANZ / Boehringer Ingelheim Australia COPD Travel Award

Alen Faiz

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award

Eskandarain Shafuddin

TSANZ/JRS Early Career Development Award

Jemma Seyfang

Janet Elder International Travel Awards

Mid-Career Award Recipient: Kimberley Wang

Early Career Award Recipient 1: Vikas Goyal

Early Career Award Recipient 2: Yet H Khor

TSANZ Respiratory Nurse Career Development Award for Indigenous Research

Betty Poot

Christine Sullivan

Maurice Blackburn ASM Travel Award

Leona Dowman

Shine a light a lung cancer PhD 2019

Kanishka Rangamuwa

David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis Research 2019

Archana Gaikwad

Shine a light on lung cancer grant-in-aid

Surein Arulananda

Lung Foundation Australia/ Eleanor Greenwood Memorial Grant in Aid for Interstitial Lung Disease Research

Yet Hong Khor

Lung Foundation Australia /Lizotte Family Research Award for Interstitial PF Research

Leona Dowman

Lung Foundation Australia /Ludwig Engel GIA for Physiological research

Katrina Tonga

Lung Foundation Australia /Ivan Cash Research GIA – IPF

Adelle Jee

Lung Foundation Australia /Cochrane

Jenifer Liang

Shine a light on lung cancer nursing/allied health fellowship in lung cancer research

Vanessa Brunelli

Lung Foundation Australia Travel Awards: Menarini Travel Grants

ERS – Hannah O’Farrell and Jack Bozier

ATS – Thomas Altree and Razia Zakarya

APSR – Leanne Ross and Hai Bac Tran

Lung Foundation Australia/Eleanor Greenwood Memorial ILD Travel Grant

Cecilia Prele

Michael Schuliga

Jade Jaffar

 

SIG AWARDS

Supported by TSANZ

Cell, Immunology and Molecular Biology: Dhammika Leshan

Evidence-based Medicine and Practice: Yet Hong Khor

Peter van Asperen Paediatric: Kiara Sclip

Physiotherapy: Jamie Wood

Respiratory Infectious Disease: Benjamin Diggins

Tobacco: Henry Gomez

Supported by Asthma Australia

Asthma & Allergy: Teresa Williams

Supported by National Asthma Council

Asthma & Allergy : Cherry Thompson

Supported by Lung Foundation Australia

Pulmonary Physiology and Sleep, John Reid Prize: Graeme Zosky

David Serisier Memorial Award for Translational Research in Bronchiectasis: Su Wei Khung

Supported by Cystic Fibrosis Australia

Cystic Fibrosis: Elena Schneider-Futschik

Supported by Maurice Blackburn

Lung Cancer: Lara Edbrooke

Occ Env Lung Disease / Population Health: Edward Harris

Palliative Care and Symptom Support: Thomas Moran

Supported by Carroll & O’Dea

Interventional Pulmonology and Bronchoscopy: Deirdre Fitzgerald

Supported by Boehringer Ingelheim

Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease: Jemma Seyfang

Primary Care: Mary Roberts

Chronic Obstructive Pulmonary Disease: Sonia Cheng

Respiratory Nurses: Jane Neil

TSANZ Best Poster: Kris Nilsen: A new tool to monitor disease in IPF

CONGRATULATIONS TO…

TSANZ would also like to take this opportunity to congratulate the following New Fellows for 2019:

  • Prof Anne Holland
  • Dr Denise O’Driscoll
  • Dr Jane Bourke
  • A/Prof Jeff Garrett
  • Prof Paul Foster
  • Prof Peter Eastwood
  • Prof Sandra Hodge

 

Open Awards

Thoracic Society Awards

AstraZeneca Respiratory Research Fellowships – closes 2nd June 2019

Vertex Adult Cystic Fibrosis Research Award – closes 2nd June 2019

Vertex Paediatric Cystic Fibrosis Research Award – closes 2nd June 2019

Lung Foundation Awards

Lung Foundation Australia Brian Eaton Memorial PhD Scholarship in IPF – closes 10th June 2019

Lung Foundation Australia Diana Cox PhD Scholarship in IPF – closes 10th June 2019

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ATS: 22nd March 2019 (5pm AEST)

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 24.4 2019

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

Helen E. Jo, Ian Glaspole, Nicole Goh, Peter M.A. Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, Eugene Haydn Walters, Christopher Zappala, Heather Allan, Sacha Macansh, Christopher Grainge, Gregory J. Keir, Andrew Hayen, Douglas Henderson, Sonja Klebe, Stefan B. Heinze, Anne Miller, Hannah C. Rouse, Edwina Duhig, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Samuel R. McCormack, Bernard Ng, David B. Godbolt, Tamera J. Corte

DOI: 10.1111/resp.13427 

Distribution of participants in the Australian IPF Registry

 

A consensus opinion amongst stakeholders as to benefits of obstructive sleep apnoea treatment for cardiovascular health

Shane A. Landry, Siobhan Banks, Peter A. Cistulli, Garun S. Hamilton, Laure Héraud, Kristina Kairaitis, Steven Lubke, Sutapa Mukherjee, Teanau Roebuck, Joesph Soda, Darren Umbers, Shantha M. W. Rajaratnam, Darren Mansfield.

DOI: 10.1111/resp.13413

 

From left to right: Prof Shantha Rajaratnam, Dr Shane Landry, A/Prof Darren Mansfield from Monash University and the Monash Medical Centre in Melbourne, Australia

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 
 

.

VOLUME 6.03 – MARCH 2021

VOLUME 3.09 DECEMBER 2018

Research Roundup:

December 2018

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have two awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS19!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 14 Feb 19

TSANZ Indigenous Respiratory Nursing Award – closes 31 Jan 19

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 23.12 (December 2018)

Inflammation-dependent and independent airway remodelling in asthma

John G. Elliot, Peter B. Noble, Thais Mauad, Tony R. Bai, Michael J. Abramson, Karen O. McKay, Francis H.Y. Green, Alan L. James

DOI: 10.1111/resp.13360

 

1000-fold magnification of the airway smooth muscle layer with a counting grid overlay for planimetry assessment of the airway smooth muscle area.

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

Canan Gündüz, Ozen K. Basoglu, Jan Hedner, Ding Zou, Maria R. Bonsignore, Holger Hein, Richard Staats, Athanasia Pataka, Ferran Barbe, Pavel Sliwinski, Brian D. Kent, Jean Lois Pepin, ​​​​​​​Ludger Grote, on behalf of the European Sleep Apnea Database Collaborators.

DOI: 10.1111/resp.13372

 

ESADA researchers and collaborators from left to right: Holger Hein, Sven Svedmyr, Ding Zou, Canan Gündüz, Ludger Grote.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X